The health insurance giant reported growth throughout its business and boosted its earnings guidance for the full year.
Healthcare-focused investors had a solid week, but shareholders of this one ETF did the best.
The trends look good for healthcare real estate -- is this the way to play it?
One of the top two pharmacy benefits managers is at risk of losing a major chunk of its business, while the other is on a clear growth path. But there are other fundamentals to consider.
Anthem is looking to get $3 billion it claims Express Scripts owes it.
Insurers allegedly denying eligible patients access to pricey new Hepatitis C drugs will have their day in court.
The health insurance giant hasn't made any gains over the past year. Here's why it could be poised for a fall.
Why the big PBM's stock might be less risky than it's been in a long time.
Investors bid up shares today after the company reported record quarterly results.
Record quarterly revenue showed continued strong demand for healthcare staffing.